What You Should Know:
- Thermo
Fisher Scientific Inc. has entered into a definitive agreement to acquire
Mesa Biotech, Inc., a San Diego,
CA-based molecular diagnostic company, for approximately $450 million in cash.
Under the terms of the agreement, Thermo Fisher will pay up to an additional
$100 million in cash upon the completion of certain milestones following the
close of the transaction.
- Mesa Biotech designs, develops, manufactures, and commercializes next generation Rapid PCR
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
87% of Americans Want to Receive COVID-19 Vaccine Information From Their Providers
What You Should Know:
According to a recent Updox survey, 87% of Americans say
they want to receive information from their healthcare provider on COVID-19
vaccine-related news/updates, with their healthcare providers cited as the most
trusted source on the topic (34%) -- behind health protection agencies (32%),
government entities (9%), and the biotechnology companies developing the
vaccines (4%).
When it comes to means of communication with their
healthcare provider, consumers’
Read More
Uber, Moderna Partner to Increase Access to COVID-19 Vaccines
What You Should Know:
- Moderna and Uber announced a partnership to work together initially to provide accessible, credible information on COVID-19 vaccine safety through Uber’s in-app messaging.
- The two companies will also work with public health and
other organizations to identify additional opportunities to support ongoing
efforts to broaden access to COVID-19
vaccines.
- Additional options being evaluated include incorporating
ride scheduling directly into the immunization
Read More
CVS Health to Provide In-Home Chemotherapy with Cancer Treatment Centers of America
What You Should Know:
- Today, CVS Health announced a collaboration with Cancer
Treatment Centers of America (CTCA) to provide in-home chemotherapy for
clinically eligible and fully insured patients.
- The program, which leverages CVS Health’s home infusion
service, Coram, and CTCA’s expertise as a top oncology care provider, aims to
minimize immunocompromised patients’ exposure to COVID-19 by offering an
alternative to inpatient or in-office cancer care.
- Through this program,
Read More
Komodo Health Acquires Cloud-Based Life Sciences Platform Mavens- M&A
What You Should Know:
- Komodo Health announces the acquisition of Mavens, a cloud-based platform for life sciences to expand its software capabilities.
- The acquisition of Mavens offers customers a cloud-based platform with a suite of software that ends reliance on fragmented data and expensive single-point solutions.
Komodo Health today announced its acquisition of Mavens, a leader in cloud-based technology solutions for the life sciences. The acquisition will enable Komodo
Read More
Verily, Broad, Microsoft Partner to Expand Life Sciences Research with Azure Cloud
What You Should Know:
- Verily and The Broad Institute have partnered with
Microsoft to expand health and life sciences research utilizing the Microsoft
Azure cloud.
- The new partnership brings together Microsoft’s cloud, data, and AI technologies, and a global network of more than 168,000 health and life sciences partners to accelerate the development of global biomedical research through the Terra platform, provide greater access and empower the open-source community.
Broad
Read More
20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
Dr. Justin Graham, Chief Medical Officer, GYANT
The rapid development of a COVID-19 vaccine is a monumental achievement, but it does nothing to address our extremely fragmented healthcare system. In 2021, policymakers must create and extend incentives to providers to work together to keep patients healthy rather than maximize profit. The pandemic has devastated the traditional fee-for-service budgets of many healthcare systems, and it isn't clear they will ever be able to catch up without
Read More
Gladskin’s President Skyler Stein Talks Endolysin Technology – Q/A
We recently spoke with Skyler Stein, President of Dutch biotechnology company Gladskin to learn more about its global endolysin technology that uses its science to improve inflammatory skin conditions by rebalancing the skin microbiome. Gladskin's parent company, Micreos, raised about $36.7M in funding last year for its endolysin technology that is poised to replace many antibiotics and overcome some of the challenges of antimicrobial resistance.
HITC: Skyler, can you speak more
about
Read More
Vaccine Safety Expert Shares 5 COVID-19 Vaccine Facts to Protect 2021
Now more than ever, public confidence is key. It's our job as medical professionals, the FDA's job, and public figures' job to convince the population to vaccinate by presenting the real results of studies.
The current vaccine hesitancy, which might result in a large proportion of people refusing vaccination, will leave us with an ongoing global crisis, even with the best vaccines ever made. A vaccine only works if it is actually administered.
Five Vaccine Facts to Protect
Read More
Verily Nabs $700M to Expand Baseline, Verily Health Platforms
What You Should Know:
- Verily, a subsidiary of
Alphabet focused on life sciences and healthcare announced it has raised $700M
from current investors, including Alphabet, Silver Lake, Temasek, Ontario Teachers’ Pension Plan and others.
- The company plans to use the capital to support rapid
expansion of some of Verily’s leading commercial businesses including Baseline, an end-to-end ecosystem
designed to make clinical research more efficient; and Verily Health Platforms,
which supports
Read More
